<title>XenoPort, Inc. (XNPT) News & Commentary

AOL.com
About Us
Follow Us :

DJIA	15,303.10	8.60	0.06%
NASDAQ	3,459.14	-0.28	-0.01%
S&P 500	1,649.60	-0.91	-0.06%

Recent Quotes Watchlist Portfolios

+ Add to Portfolio

XenoPort Resumes Horizant Supply - Analyst Blog

5/22/2013 by Zacks

XenoPort Candidate Disappoints - Analyst Blog

5/21/2013 by Zacks

UPDATE: Deutsche Bank Reiterates Buy, Lowers PT on XenoPort on Disappointing Results

5/21/2013 by Benzinga

UPDATE: Wedbush Downgrades XenoPort as Arbaclofen Fails in Phase III of MS Spasticity Trial

5/20/2013 by Benzinga

XenoPort's CEO Presents at Special Conference (Transcript)

5/20/2013 by Seeking Alpha

Why XenoPort Shares Stumbled

XenoPort writes the wrong prescription for shareholders when it announced top-line data for a late-stage clinical trial.

5/20/2013 by DailyFinance

Morning Market Losers

5/20/2013 by Benzinga

XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multipl

5/20/2013 by DailyFinance

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

5/20/2013 by Smart Money

XenoPort Provides Update on Availability of Horizant

5/17/2013 by DailyFinance

See More Articles...